Inżynier i Fizyk Medyczny 2/2017 vol. 6
101
artykuł
/
article
radioterapia
/
radiotherapy
Zalecamy stosowanie aktualnych wytycznych w codziennej
praktyce i dalsze poszerzanie wiedzy dla lepszego zrozumienia
idei ochrony narządów krytycznych.
Literatura
1.
M.A. Coffeya, L. Mullaneyb, A. Bojenc, et.al.:
Recommended ESTRO
Core Curriculum for RTTs (Radiation TherapisTs) – 3
rd
edition
, 2011.
2.
European Higher Education Area Level 6 –
Benchmarking docu-
ment for Radiation TherapisTs, ESTRO
, 2014.
3.
K.S. Saladin:
Human Anatomy: 2
nd
edition
, 2008.
4.
W. Woźniak:
Anatomia człowieka: Podręcznik dla studentów i le-
karzy
, Elsevier Urban & Partner, Wrocław 2003.
5.
S. Ying, Y. Xiao-Li, L. Wei et.al.:
Recommendation for a contouring
method and atlas of organs at risk in nasopharyngeal carcinoma
patients receiving intensity-modulated radiotherapy
, Radiothera-
py and Oncology, 110, 2014, 390-397.
6.
ICRU Report 83:
Prescribing, Recording, and Reporting Photon-Be-
am Intensity-Modulated Radiation Therapy (IMRT)
, Journal of the
ICRU, 10(1), 2010.
7.
R.B. Marcus Jr, R.R. Million:
The incidence of 453 myelitis after
irradiation of the cervical spinal cord
, Int J Radiat Oncol Bio Phys,
19, 1990, 3-8.
8.
W. Hasler, C.R. Boland, M. Feldman:
Gastroenterology and Hepa-
tology
, Current Medicine US, 2, 2002.
9.
J.L. Rosenblum, A.L. Burnett:
Microsurgical Penile Revasculari-
zation, Replantation, and Reconstruc- tion
, [in:] J.I. Sandlow (ed):
Microsurgery for Fertility Specialists
, Springer, 2013, 179-221.
10.
G. Cefaro, D. Genovesi, C.A. Perez:
Delineating Organs at Risk in
Radiation Therapy
, 2013.
11.
C.L. Brouwer, R.J. Steenbakkers, J. Bourhis et.al: CT-based de-
lineation of organs at risk in the head and neck region: DAHAN-
CA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncolo-
gy and TROG consensus guidelines, 117(1), 2015, 83-90.
12.
L. Freedman:
A radiation oncologist’s guide to contour the parotid
gland
, Practical Radiation Oncology, 6, 2016,315-317.
13.
J.E. Freire, L.W. Brady, P. De Potter:
Principles and Practice of Ra-
diation Oncology
, Philadelphia, 33, 1998, 883.
14.
F. Laura, S. Charif:
A radiation oncologist’s guide to contour the
parotid gland
, Practical Radiation Oncology, 6, 2016, 315-317.
15.
E. Ziółkowska, M. Biedka, W. Windorbska:
Side effects of ra-
diotherapy in patients with head in neck cancer: mechanisms and
consequences
, Otorynolaryngologia, 10(4), 2011, 147-153.
16.
A. Urban, L. Miszczyk, B. Maciejewski:
Ocena występowania późne-
go odczynu popromiennego w obrębie ślinianek po napromienianiu
nowotworów głowy i szyi
, Otolaryngologia Pol, 59(1), 2005, 21-25.
17.
J.S. Cooper, K. Fu, J. Marks, S. Silverman:
Late effect of radiation
therapy in the head and neck region
, Int J Radiat Oncol Biol Phys,
31, 1995, 1141-1164.
18.
S.E. Taylor, E.G. Miller:
Preemptive pharmacologic intervention in
radiation – induced salivary dysfunction
, Proc Soc Exp Biol Med.,
221, 1999, 14-26.
19.
Radiation Therapy Oncology Group:
RTOG 1016 phase III trial of
radiotherapy plus cetuximab versus chemoradiotherapy in HPV-as-
sociated oropharynx cancer
, 2014.
Oncologica Piemonte
-
Valle d’Aosta” network to reduce inter
-
and
intraobserver variability
, La radiologia medica, 2016.
24.
C. Mehee, R. Tamer, S.L. Malisa:
Development of a standardized
method for contouring the larynx and its substructures
, Radiation
Oncology, 9, 2014, 285.
25.
C.L. Brouwer, R.J. Steenbakkers, E. van den Heuvel, J. Duppen
et al:
3D Variation in delineation of head and neck organs at risk
,
Radiation Oncology, 7, 2012, 32.
26.
M. Feng, C. Demiroz, A. Karen et al.:
Normal tissue anatomy for
oropharyngeal cancer: contouring variability and its impact on
optimization
, Int J Radiat Oncol Biol Phys, 84, 2012, 245-249.
27.
T.A. van de Water, H.P. Bijl, H.E. Westerlaan, et. al.:
Delineation
guidelines for organs at risk involved in radiation-induced saliva-
ry dysfunction and xerostomia
, Radiotherapy and Oncology, 93,
2009, 545-552.
28.
W. Jackowiak, B. Bak, A. Kowalik, et.al;
Influence of the type of
imaging on the delineation process during the treatment planning
,
Rep. Pract. Oncol. Radiother., 20(5), 2015, 351-357.
29.
Radiation/Oncology/Toxicity/RTOG,
/
wiki/Radiation_Oncology/Toxicity/RTOG.
Źródło: Modified from Marks et al.QUANTEC Quantitative Analysis of Normal Tissue Radiation Effects in the
Clinic, CRT conformal radiotherapy, SRS stereotactic radiosurgery, GTV gross tumor volume, RILD radiation-
-induced liver disease, RTOG Radiation Therapy Oncology Group, BED biologically equivalent dose, SBRT ste-
reotactic body RT, FLT4 tyrosine protein kinase receptor FLT4.
Tabela 7
Dawka tolerancji dla krtani wg. QUANTEC
20.
J.E. Fischer, K.I. Bland, et.al.:
Chirurgia;
Głowa i szyja. Narządy wewnętrznego wy-
dzielania
, Leczenie chirurgiczne raka krtani
i gardła dolnego
, 10, 2010, 1-21.
21.
L. Best, G. Rodrigues, et. al.:
Radiation on-
cology primer and review: essential concept
and protocol 5.9
, 89, 2013.
22.
L. Freedman:
A radiation oncologist’s guide
to contouring the larynx
, Practical Radiation
Oncology, 6, 2016, 129-130.
23.
C. Domenico, P. Edoardo, P. Cristina:
Deli-
neation of the larynx as organ at risk in ra-
diotherapy: a contouring course within “Rete
reklama
